Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for Osteopenia Due to Acute Leukemia
IRCT20200916048733N1Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of alendronate in osteopenia, acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), sponsored by Tabriz University of Medical Sciences. Started Mar 2020; status: completed.
02
Drugs
alendronate
03
Conditions
osteopeniaacute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on IRCT20200916048733N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200916048733N1.